# Trade Mark Journal No.2026/007 13 February 2026

## WO0000001899471 (5)

Office of origin: United States of America

Date of International Registration:24 December 2025
Date of designation in the UK: 24 December 2025

International priority date claimed: 22 July 2025 (United States of America) (99296442)

Class 5
  Pharmaceutical preparations for the treatment of eye diseases and conditions; ocular pharmaceuticals.

Leadiant Biosciences, Inc.

Representative: Michael N. Mercanti Lucas & Mercanti, LLP, 100 South Jefferson Road, Suite 202, Whippany NJ 07981, UNITED STATES OF AMERICA